Although there are guidelines and strong evidence supporting early use, GLP-1 receptor agonists are still underused in clinical practice for a multitude of reasons, including reimbursement, prior authorizations and access. On Aug. 15, join us for a program that aims to close this gap by providing pharmacists with the latest clinical insights and effective communication strategies for GLP-1 medications. Learn more and register by clicking here.
NCPA
